Cargando…
Efficacy and safety of Samtropin™ recombinant human growth hormone; a double-blind randomized clinical trial
BACKGROUND: Recombinant human growth hormone (rhGH) can increase the growth rate in growth hormone deficient children (GHD). In this randomized clinical trial, we compared the efficacy and side effects of an Iranian brand; Samtropin with Norditropin. METHODS: The GHD children were randomly treated e...
Autores principales: | Tabatabaei-Malazy, Ozra, Mohajeri-Tehrani, Mohammad Reza, Heshmat, Ramin, Taheri, Eghbal, Shafiee, Gita, Razzaghy-Azar, Maryam, Rabbani, Ali, Qorbani, Mostafa, Adibi, Hossein, Shahbazi, Samimeh, Karimi, Farzaneh, Rezaian, Sheema, Larijani, Bagher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304100/ https://www.ncbi.nlm.nih.gov/pubmed/25648850 http://dx.doi.org/10.1186/s40200-014-0115-0 |
Ejemplares similares
-
Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial
por: Heshmat, Ramin, et al.
Publicado: (2012) -
Who are diabetic foot patients? A descriptive study on 873 patients
por: Madanchi, Nima, et al.
Publicado: (2013) -
Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar(®) in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial
por: TABATABAEI-MALAZY, Ozra, et al.
Publicado: (2018) -
Prevalence of Dyslipidemia in Iran: A Systematic Review and Meta-Analysis Study
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2014) -
Editorial: Reducing the Burden of Age-Related Disease in Relation to Osteoporosis, Sarcopenia and Osteosarcopenia
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2022)